Practical consensus recommendation on when to do BRCA testing.

-mutation associated breast cancer and to future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for and mutations is available, mutation status can be considered when making treatment and prevention decisions for testing, mutation carriers with breast cancer. Expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.